NIFTY 50

It is a win-win deal for HUL and GSK says, Milind Sarwate of Increate Value Advisors

Updated : December 03, 2018 10:44 PM IST

Unilever is to buy GlaxoSmithKline's Horlicks nutrition business for $3.8 billion, boosting the Anglo-Dutch group's position in India with the addition of the malted drink.

The deal, announced on Monday, increases the consumer goods giant's footprint in one the world's fastest-growing economies and marks a notable addition to the portfolio by outgoing chief executive Paul Polman, who steps down in January.

Sunil Alagh, founder and chairman, SKA Advisors; Milind Sarwate, founder and CEO, Increate Value Advisors and Girish Vanvari, tax expert.

Milind Sarwate said, “It is a good win-win deal for both HUL and GSK, simply because the reasons for this decision from both sides are different."

GSK is doing it more for reorganising their global strategic portfolio whereas HUL is doing it to add to its India’s presence and build complementarity into its health portfolio, Sarwate said.
primo org
Have you signed up for Primo, our daily newsletter?
It has all the stories and data on the market, business, economy and tech that you need to know.
cnbc two logos
To keep watching CNBC-TV18, India's No. 1 English Business News Channel, call your Cable or DTH Operator and subscribe now for just Rs. 4 per month. You can also subscribe to CNBC-TV18 Prime HD for Re 1/- per month.Find out more
Live TV